🇺🇸 Iv Methylprednisolone in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 10

Most-reported reactions

1. Anaphylactic Reaction — 1 report (10%)
2. Anxiety — 1 report (10%)
3. Breast Cancer Stage Iv — 1 report (10%)
4. Completed Suicide — 1 report (10%)
5. Delirium — 1 report (10%)
6. Drug Effect Decreased — 1 report (10%)
7. Drug Hypersensitivity — 1 report (10%)
8. Drug Ineffective For Unapproved Indication — 1 report (10%)
9. Drug Interaction — 1 report (10%)
10. Encephalitis — 1 report (10%)

Source database →

Frequently asked questions

Is Iv Methylprednisolone approved in United States?

Iv Methylprednisolone does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Iv Methylprednisolone in United States?

Göteborg University is the originator. The local marketing authorisation holder may differ — check the official source linked above.